FOLH1 and neoplasm: One particular promising approach is the use of PSMA-specific TGFß-receptor dominant-negative autologous CAR T-cells to help facilitate continuous proliferation of CAR T-cells and enhance their antitumoral potential by suppressing the tumor microenvironment.